title: Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction.
authors: Giuseppe
authors: G
authors: Patti
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D000069059:Atorvastatin; D015415:Biomarkers / Q000097:blood; D017023:Coronary Angiography / Q000009:adverse effects; D003324:Coronary Artery Disease / Q000150:complications / Q000000981:diagnostic imaging / Q000628:therapy*; D052279:Creatine Kinase, MB Form / Q000097:blood; D003404:Creatinine / Q000097:blood; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine; D005919:Glomerular Filtration Rate; D006538:Heptanoic Acids / Q000008:administration & dosage*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D007674:Kidney Diseases / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D009203:Myocardial Infarction / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D011758:Pyrroles / Q000008:administration & dosage*; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D015854:Up-Regulation
chemical_list: D015415:Biomarkers; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin; D003404:Creatinine; D052279:Creatine Kinase, MB Form